Join the Ubrelvy group to help and get support from people like you.
Ubrelvy News
Ubrogepant (Ubrelvy) Effective Against Early Migraine Symptoms
WEDNESDAY, May 14, 2025 – Migraines don’t just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness. What’s more, those n...
Ubrogepant During Prodromal Phase of Migraine Eases Symptoms
TUESDAY, May 13, 2025 – Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to a study published online May 12 in Nature Medicine. Peter J. Goadsby,...
Migraine Drug Ubrelvy May Stop Headaches Before They Start
THURSDAY, Aug. 29, 2024 – A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial...
Ubrogepant Administered During Prodrome Beneficial for Migraine
WEDNESDAY, Aug. 28, 2024 – For adults experiencing migraine attacks with moderate-to-severe headache pain, ubrogepant administered during prodrome is beneficial for patient-reported outcomes,...
FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine
DUBLIN, Dec. 23, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for Ubrelvy (ubrogepant) for...